Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial
Clinical Microbiology and Infection (2023) - 2 Comments
pubmed: 36096430  doi: 10.1016/j.cmi.2022.09.001  issn: 1198-743x  issn: 1469-0691 

Payam Tabarsi , Nassim Anjidani , Ramin Shahpari , Masoud Mardani , Araz Sabzvari , Babak Yazdani , Hamidreza Kafi , Newsha Fallah , Ali Ebrahimi , Ali Taheri , Nikolai Petrovsky , Saghar Barati author has email

#1 Cryptochloa capillata
#2 Saghar Barati

Attach files by dragging & dropping, selecting them, or pasting from the clipboard. Uploading your files… We don’t support that file type. with a PNG, GIF, or JPG. Yowza, that’s a big file. with a file smaller than 1MB. This file is empty. with a file that’s not empty. Something went really wrong, and we can’t process that file.

Comment must be at least 15 characters.
You have not yet installed the PubPeer browser plugin and will not see PubPeer comments on other websites. Install it here!